Cel-Sci
CVM
#9955
Rank
โ‚น2.78 B
Marketcap
โ‚น329.60
Share price
1.42%
Change (1 day)
-54.87%
Change (1 year)

Cel-Sci (CVM) - P/B ratio

P/B ratio as of March 2026 : 1.89

According to Cel-Sci 's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Cel-Sci - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-312.59-23.59%
2024-12-313.39-68.49%
2023-12-3110.7178.4%
2022-12-313.86-35.44%
2021-12-315.98-62.81%
2020-12-3116.1-65.99%
2019-12-3147.360.16%
2018-12-3129.5-671.6%
2017-12-31-5.16-280.47%
2016-12-312.86-79.02%
2015-12-3113.6203.68%
2014-12-314.49105.24%
2013-12-312.19-69.52%
2012-12-317.18-12.64%
2011-12-318.2211.11%
2010-12-317.3935.89%
2009-12-315.4457.29%
2008-12-313.46-17.36%
2007-12-314.19-116.23%
2006-12-31-25.8-289.3%
2005-12-3113.630.28%
2004-12-3110.5-52.21%
2003-12-3121.9102.53%
2002-12-3110.8

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.14 277.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
20.5 984.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
1.41-25.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-0.8883-146.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
4.20 122.19%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-5.31-380.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.7276-61.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
2.46 29.95%๐Ÿ‡บ๐Ÿ‡ธ USA